科学图书馆
-
Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP TrialD Burkhoff, BA Borlaug, SJ Shah et al. -
Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study designBehr J, Nathan SD, Harari S et al.
-
Left main coronary artery compression in pulmonary hypertensionJE Labin, R Saggar, EH Yang et al.
-
Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?Zhang H, Chen SL.
-
Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular diseaseGorter TM, Obokata M, Borlaug BA et al.
-
Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial HypertensionDai Y, Chen X, Zhou Z et al.
-
Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart DiseaseMüller J, Heck PB, Ewert P et al.
-
Updated clinical classification of pulmonary hypertensionSimonneau G, Gatzoulis MA, Adatia I et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
